Scrip Watch

Archit Organosys Ltd

Scrip Sanctuaries for protection from the wildlife in this jungle of Indian Equities

Archit Organosys Ltd

Archit Organosys Ltd
Commodity Chemicals
FV – Rs 10; 52wks H/L – 88.85/19.55; TTQ – 9.54 Lacs; CMP – Rs 61.9 (As On October 13, 2017);                      
Market Cap – Rs 59 Crs

Standalone Financials and Valuations for FY17 (Amt in Rs Crs unless specified)


Equity Capital

Net worth
Long Term Debt
Total  
Sales
PAT
BV
(Rs)

EPS (Rs)

P/E

Industry P/E

P/BV

Promoter’s
Stake
Beta
10.04 27 20 48 1.56 27 1.6 38.7 18.9 2.3 51.07 -0.61

Promoter holding in Dec,2016 was 27.09%

Standalone Financials and Valuations for Q1 FY18


Equity Capital

Net worth
Long Term Debt
Total  
Sales
PAT
BV
(Rs)

EPS (Rs)

P/E

Industry P/E

P/BV

Promoter’s
Stake
Beta
10.04 25 20 11 -1.94 25 -1.93 18.9 2.5 51.07 -0.61

 

Valuation Parameters:

  1. Long Term Debt to Equity – 0.7
  2. ROE % – 6
  3. Market Cap/Sales – 1.22

Company has developed in house quality products of SMCA powder in to crystal form for the first time in Indian market. This product is developed by Mr. Archit Amin, who has studied in U.S.A. This will fetch good business in export markets with better profitability.

Industry wise domestic utilization rates are expected to reach high levels of 90 % by the end of 2018, given the healthy growth in the end-user market.

In order to expand Companies current manufacturing operations, the Company is in the process of establishing a new manufacturing facility at Narmad (“Bhavnagar Facility”) on a land area admeasuring 56,656 sq. mtrs. In this regard, Company has purchased the land and has started construction of the proposed plant. The Bhavnagar Facility will add to the production capacity of Monochloroacetic Acid (MCA) and Sodium Monochloro Acetate (SMCA) and will add Chloro Acetyl Chloride (CAC) as well as Polyaluminium Chloride (PAC) to Company’s product portfolio.

During the year the company has allotted 10042200 partly paid Equity Shares having face value of Rs. 10 each at a price of Rs. 25per share (including premium of Rs. 15). Rs. 12.50 (Rs. 5 per share towards face value and Rs. 7.50 per share towards share premium) has been received by the Company on application and the remaining amount be payable on first and final call as and when the same is made.

 

Overview:

  • Archit Organosys Ltd is engaged in the business of dealing and manufacturing of chemicals.
  • The Company’s products include Mono Chloco Acetic Acid and Ethyle Acetate.
  • The Company produces a range of organic chemicals, pigments, specialty derivatives, cosmetic products, adhesives and sealants.
  • The Company’s monochloroacetic acid and sodium monochloroacetate are used in the synthesis of various agricultural chemicals, cosmetic surfactants, oil drilling chemicals and plastic additives.
  • The Company’s Marval is a plant growth enhancer, which is made from organic plant waste. Marval contains natural trace elements, simple and complex sugars in a balanced form. Marval also contains phenolic compounds and cytokinins.
  • The Auxins in Marval are naturally occurring plant growth hormones.
  • The Company’s coatings include AOL RUBBOCOAT and AOL ROOF & GUTTER SEALANTS. RubboCoat is  single component rapid drying paint. RubboCoat is used for vehicle underbody and roof tops.

Management:

  • Kandarp Amin – Chairman
  •  Bharatkumar Shrimali  – CFO

 

The Equity Capital is @ Rs 10.04 Crs consisting of 10042200 equity Shares of FV Rs 10 currently held as under

 

None Of the Promoter’s Holding is pledged.

Major Non – Promoter Holdings:

Non – Promoters No. of shares held % of shares held
Munjal Mahendrabhai Patel 237500 4.73
Mansi Munjal Patel 237500 4.73
Patel Rakesh Rameshchandra 515000 3.42
Patel Sanjaykumar Rameshbhai 500000 9.96
Sagar Samir Shah 475000 3.15
Arihant Capital Mkt. Ltd. 158213 1.05

 

 

Standalone Financial Trends (In Rs.Crs) :

Particulars FY17 FY16 FY15 FY14
Equity Paid Up 10.04 5.03 5.52 4.73
Networth 27 13 6 5
Total Debt 30 10 8 7
Net Sales 48 52 56 49
Other Income 0.3 0.5 0.8 0.1
PAT 1.56 1.47 0.8 0.6
Book Value (Rs) 27 26 11 11
EPS (Rs) 1.6 2.9 1.4 1.3

 

 

 

Excerpts from Gaurav’s Blog

Losers Focus on Winners – Winners Focus on Winning   Workshop Conceptualised & Conducted by GAURAV A PARIKH Stock Markets ~ Minting Millions ~ TOP 10 Winning Moves Grabbing Short Term Too While Compounding Long Term Post Pandemic lock-down, this is the First Fundamental Direct Equity ‘Value Vs Price’ Workshop in over Two and a Half Years by Gaurav Parikh and Jeena … Mumbai Equity Workshop ~ Saturday April 30 2022 ~ Almost Full ~ Top 10 Winning Moves Read More » The post Mumbai Equity Workshop ~ Saturday April 30 2022 ~ Almost Full ~ Top 10 Winning Moves first appeared on Gaurav's Blog. [...]

  Rest in Peace now Gerela Saab  ! Mr S T Gerela ex GM of BSE passed away peacefully this morning We had not met in years but he always remained at the top of my mind when it came to testimonials for this is what he had said to me over a decade ago,when … RIP S T Gerela ex GM BSE ~ gave me the best compliment till date Read More » The post RIP S T Gerela ex GM BSE ~ gave me the best compliment till date first appeared on Gaurav's Blog. [...]

Vedanta de-listing offer price Rs 87.50~Come on Mr Anil Agarwal ! Promoter Group of  Vedanta Ltd has proposed a voluntary de-listing at an indicative offer price of Rs 87.50~are the over 7.3 lakh minority shareholders from Alibag !? …apologies to the people of Alibag Some would term this as De-listing Duplicity ~ but I would … Vedanta de-listing offer price Rs 87.50~Come on Mr Anil Agarwal ! Read More » The post Vedanta de-listing offer price Rs 87.50~Come on Mr Anil Agarwal ! first appeared on Gaurav's Blog. [...]

This is a Riskless Reliance Industries Rights Investment Strategy for those over 2.3 Million Shareholders already holding RIL shares. It is not a recommendation to buy RIL cum rights  It’s a no brainer yet I’m just penning a brief note because some have told me they hold Reliance but are skipping the Rights ! Don’t … Riskless Reliance Industries Rights Investment Strategy Read More » The post Riskless Reliance Industries Rights Investment Strategy first appeared on Gaurav's Blog. [...]

 Wealth is negotiable, Health is not Your Personal Well Being is more important that the Stock Market Well Being ~ Always & more so in this unfathomable ongoing Covid-19 Reality Above’s a three minute reach out by me last night to all connected with me to reinforce this .It’s also posted on Facebook , … Covid-19 Crisis-Your Well Being is more important than Stock Market Well Being Read More » The post Covid-19 Crisis-Your Well Being is more important than Stock Market Well Being first appeared on Gaurav's Blog. [...]